Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

A Vulnerable, Membrane-Proximal Site in Human Respiratory Syncytial Virus F Revealed by a Prefusion-

Journal Article · · J. Virol.
DOI:https://doi.org/10.1128/JVI.02279-20· OSTI ID:1785007
; ; ; ; ; ;

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; FOREIGN
OSTI ID:
1785007
Journal Information:
J. Virol., Vol. 95, Issue (11)
Country of Publication:
United States
Language:
ENGLISH

References (31)

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study journal September 2017
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants journal July 2020
Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients journal October 2009
Effects of Anti-G and Anti-F Antibodies on Airway Function after Respiratory Syncytial Virus Infection journal July 2014
Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial journal December 2015
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state journal February 2017
A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein journal September 2019
Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors journal December 2016
Antigenic Structure of Human Respiratory Syncytial Virus Fusion Glycoprotein journal August 1998
Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention journal February 2012
Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera journal October 2015
Clinical Potential of Prefusion RSV F-specific Antibodies journal March 2018
Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation journal February 2018
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus journal October 2013
Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract journal May 2007
Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein journal July 2015
Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming journal December 2009
Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody journal April 2013
Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus journal January 2017
Identification of epitopes on respiratory syncytial virus proteins by competitive binding immunoassay. journal January 1986
Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV journal April 2016
Neutralization of Human Respiratory Syncytial Virus Infectivity by Antibodies and Low-Molecular-Weight Compounds Targeted against the Fusion Glycoprotein journal June 2010
A proof of concept for structure-based vaccine design targeting RSV in humans journal August 2019
Novel Human Monoclonal Antibody Combination Effectively Neutralizing Natural Rabies Virus Variants and Individual In Vitro Escape Mutants journal July 2005
A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-human Primates journal November 2018
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia journal October 2013
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies journal June 2020
Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein journal November 2017
High efficiency transformation by electroporation of Pichia pastoris pretreated with lithium acetate and dithiothreitol journal January 2004
The Comparative Genomics of Human Respiratory Syncytial Virus Subgroups A and B: Genetic Variability and Molecular Evolutionary Dynamics journal May 2013
A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism journal September 2015

Similar Records

Related Subjects